BB Biotech AG
Investment company focused on public biotechnology firms developing novel drugs.
BION | SW
Overview
Corporate Details
- ISIN(s):
- CH0027659793 (+1 more)
- LEI:
- 391200MBZQNPFHIVKO34
- Country:
- Switzerland
- Address:
- Schwertstrasse 6, 8200 Schaffhausen
Description
BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-25 07:00 |
BB Biotech: Preliminary full-year 2024 results and dividend proposal
|
English | 24.0 KB | ||
| 2025-01-24 07:00 |
BB Biotech: Preliminary full-year 2024 results and dividend proposal
|
English | 24.0 KB | ||
| 2025-01-24 01:00 |
EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
|
English | 18.1 KB | ||
| 2025-01-24 01:00 |
EQS-News: BB Biotech: Vorläufige Jahresergebnisse 2024 und Dividendenvorschlag
|
German | 19.0 KB | ||
| 2025-01-24 01:00 |
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
|
English | 5.0 KB | ||
| 2025-01-24 01:00 |
EQS-Adhoc: BB Biotech AG mit Gewinn im Geschäftsjahr 2024
|
German | 5.1 KB | ||
| 2024-10-25 02:00 |
EQS-Adhoc: BB Biotech AG publishes its interim report
|
English | 4.9 KB | ||
| 2024-10-25 02:00 |
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
|
German | 5.0 KB | ||
| 2024-10-25 02:00 |
EQS-News: BB Biotech: Strategic reallocation of portfolio assets progressing
|
English | 20.7 KB | ||
| 2024-10-25 02:00 |
EQS-News: BB Biotech: Strategische Reallokationen im Portfolio setzen sich fort
|
German | 21.6 KB | ||
| 2024-10-25 00:00 |
Q3 statement / Q3 financial report 2024
|
English | 2.9 MB | ||
| 2024-09-18 17:40 |
BB BIOTECH AG: Dr. Thomas von Planta, buy
|
English | 7.7 KB | ||
| 2024-07-31 17:40 |
BB BIOTECH AG: Dr. Thomas von Planta, buy
|
English | 7.7 KB | ||
| 2024-07-26 07:00 |
BB Biotech AG publishes its interim report and announces a new head of its inve…
|
English | 7.8 KB | ||
| 2024-07-26 02:00 |
EQS-News: Substantial pipeline progress at several portfolio companies offsets …
|
English | 24.9 KB |
Automate Your Workflow. Get a real-time feed of all BB Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BB Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BB Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | N/A | Non-Executive member | Buy | None | 40,893.80 CHF |
| 2024-09-16 | N/A | Non-Executive member | Buy | None | 47,103.20 CHF |
| 2024-07-29 | N/A | Non-Executive member | Buy | None | 54,913.50 CHF |
| 2024-04-30 | N/A | Non-Executive member | Buy | None | 41,450.00 CHF |
| 2024-03-25 | N/A | Non-Executive member | Buy | None | 55,167.50 CHF |
| 2024-03-22 | N/A | Non-Executive member | Buy | None | 105,927.16 CHF |
Peer Companies
